• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Evidence Based Recommendations for Supportive Care in Multiple Myeloma
Conclusion:Along with anti-myeloma chemotherapy therapy, management of complications (anemia, infections, renal insufficiency) and other associated symptoms is necessary to improve the quality of life.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - November 21, 2018 Category: Hematology Authors: Qureshi, A., Tariq, M. J., Shah, Z., Abu Zar, M., Aslam, S., Rafae, A., Malik, M. N., Kamal, A., Jose, J. A., Selene, I. I., Shafqat, M., Jamil, F., Durer, S., Durer, C., Anwer, F. Tags: 653. Myeloma: Therapy, excluding Transplantation: Poster I Source Type: research

Immunogenicity of 13-valent conjugate pneumococcal vaccine in patients 50 years and older with end stage renal disease on dialysis.
Abstract Patients with end stage renal disease (ESRD) on dialysis are at increased risk of pneumococcal disease. We evaluated the immunogenicity of 13-valent pneumococcal conjugate vaccine (PCV13) in this population. Eligible patients with ESRD on dialysis were given a single dose of PCV13 vaccine. Serum antibody concentrations against 13 pneumococcal capsular polysaccharides were measured at baseline, 2 months (m) and 12m post-vaccination. Response to vaccine was defined as a ≥ 2-fold increase in antibody concentration from baseline and an absolute post-vaccination value of at least 1 μg/ml. Seventeen patients...
Source: Clinical and Vaccine Immunology - August 30, 2016 Category: Allergy & Immunology Authors: Mitra S, Stein GE, Bhupalam S, Havlichek DH Tags: Clin Vaccine Immunol Source Type: research